Ellicott City, MD, United States of America

Ami A Shah

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.2

ph-index = 1


Location History:

  • Ellicot City, MD (US) (2020)
  • Ellicott City, MD (US) (2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ami A Shah in Cancer Research

Introduction

Ami A Shah is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of cancer research, particularly in the assessment and treatment of cancer risks associated with autoimmune diseases. With a total of 2 patents, his work is paving the way for advancements in medical science.

Latest Patents

Ami A Shah's latest patents include innovative materials and methods for assessing cancer risk and treating cancer. This document relates to materials and methods for assessing and/or treating subjects, particularly those with autoimmune diseases. For instance, the materials and methods provided can determine if a subject has one or more antibodies that indicate a lower or higher risk of cancer. Additionally, the patents offer materials and methods for treating individuals identified as having a higher cancer risk.

Another significant patent focuses on autoimmune antigens and cancer. Autoimmune diseases are believed to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Analyses of peripheral blood lymphocytes and serum have suggested that mutations in autoimmune antigen targets can spark cellular immunity and cross-reactive humoral immune responses. This acquired immunity to autoimmune antigens may help control naturally occurring cancers.

Career Highlights

Ami A Shah is affiliated with The Johns Hopkins University, where he continues to engage in groundbreaking research. His work is instrumental in bridging the gap between autoimmune diseases and cancer treatment, showcasing his commitment to improving patient outcomes.

Collaborations

Ami collaborates with esteemed colleagues, including Livia Angela Casciola-Rosen and Antony Rosen. These partnerships enhance the depth and breadth of his research, contributing to the advancement of knowledge in the field.

Conclusion

Ami A Shah's innovative work in cancer research exemplifies the intersection of autoimmune diseases and cancer treatment. His patents reflect a commitment to improving healthcare and advancing scientific understanding. The impact of his contributions is significant and continues to inspire further research in this vital area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…